🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › Utah › Salt Lake City

በSalt Lake City፣ UT ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 27 ጥናቶች በSalt Lake City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06982521

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Trial Site, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Utah Cancer Specialists, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Huntsman Cancer Institute, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07287098

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Utah Cancer Specialists, Salt Lake City
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Utah Huntsman Cancer Institute, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07100106

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Huntsman Cancer Hospital at the University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • Farmington Health Center, Farmington · 15 ማይል ርቀት
እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06774963

Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07203378

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06500481

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Utah - Huntsman Cancer Institute, Salt Lake City
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05232916

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Huntsman Cancer Institute, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05377996

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT01042379

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Huntsman Cancer Institute, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT07062965

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

ተሳታዮችን በመፈለግ ላይ
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT05297734

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Utah Cancer Specialists-Salt Lake City, Salt Lake City
  • LDS Hospital, Salt Lake City
እድሜ ከ50 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT04852887

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • START Center for Cancer Care - Mountain Region, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06395519

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ17 ማርች 2026 · NCT05291507

Improving Care for Rural Patients With Solid Tumors

ተሳታዮችን በመፈለግ ላይ
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ5 ፌብሩ 2026 · NCT04916990

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ9 ዲሴም 2025 · NCT06961955

SAVE Trial: SAfe Opioid Use Video Education

ተሳታዮችን በመፈለግ ላይ
  • University of Utah Huntsman Cancer Institute, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ26 ኖቬም 2025 · NCT07044583

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ21 ኖቬም 2025 · NCT07029490

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Salt Lake City
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦክቶ 2025 · NCT07166042

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Utah- Huntsman Cancer Center, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2025 · NCT05216432

Community Services Navigation to Advance Health Equity in Breast Cancer Screening

ተሳታዮችን በመፈለግ ላይ
  • University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences, Salt Lake City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦገስ 2025 · NCT06305312

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በSalt Lake City ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።